# Nicotine Patch Safety Study

> **NCT01655082** · PHASE2 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 160 (actual)

## Conditions studied

- Smokers

## Interventions

- **DRUG:** V0116 transdermal patch
- **DRUG:** Nicotine transdermal patch

## Key facts

- **NCT ID:** NCT01655082
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2012-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655082, "Nicotine Patch Safety Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01655082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*